FTC drops offense on Defense

Executive Summary

The Federal Trade Commission decides not to pursue investigations into health claims substantiation for Prestige Brands' Chloraseptic Defense Daily Health Strips and Insight Pharmaceuticals' Sucrets Defense lozenges in part because both products have been permanently discontinued, FTC states in June 1 letters to the companies. The Chloraseptic Defense strips claimed to boost the immune system and prevent flu and cold. Similarly, Sucrets Defense claimed to boost the immune system and fight colds as well as provide protection before entering crowded places. Other factors leading to FTC's decisions to not pursue the investigations include the short periods of time the products were marketed, the limited nature of the products' ad campaigns and relatively small resulting sales, FTC states...